GlassScriptPhysician profile
Jeffrey A Kantor
NPI 1396823431
$1,013.90
in general payments reported to CMS, 2019-2025
13 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $19.59 · 2021: $35.71 · 2022: $141 · 2023: $75.46 · 2024: $61.46 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $361.39 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $194.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $75.46 | 2023 | |
| Abbott Laboratories | $64.27 | 2022 | |
| Bioventus LLC | $61.08 | 2019-2020 | |
| Nuvasive, INC. | $48.84 | 2019 | |
| Depuy Synthes Sales INC. | $44.30 | 2021-2024 | Orthovisc |
| Fidia Pharma USA INC. | $43.92 | 2022-2024 | Hymovis, Hyalgan, Triluron |
| Vericel Corporation | $34.70 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $28.82 | 2025 | |
| Ibsa Pharma INC. | $23.37 | 2025 | Flector, Licart, Tirosint |
| Djo, LLC | $17.88 | 2024 | Procare |
| Horizon Therapeutics Plc | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kantor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.